196 related articles for article (PubMed ID: 3424375)
1. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.
Kacew S
Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
Kacew S
J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
[TBL] [Abstract][Full Text] [Related]
3. Role of phospholipase C in chlorphentermine-induced pulmonary phospholipidosis in rat.
Kacew S
Proc Soc Exp Biol Med; 1988 May; 188(1):35-9. PubMed ID: 2835777
[TBL] [Abstract][Full Text] [Related]
4. Inability of nitrendipine to protect against gentamicin nephrotoxicity in the rat.
Kacew S
Biomed Environ Sci; 1989 Jun; 2(2):160-6. PubMed ID: 2556158
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin.
Kacew S; Hewitt WR; Hook JB
Toxicol Appl Pharmacol; 1989 Jun; 99(1):61-71. PubMed ID: 2524910
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat.
Kacew S
J Pharmacol Exp Ther; 1989 Jan; 248(1):360-6. PubMed ID: 2492342
[TBL] [Abstract][Full Text] [Related]
7. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
Josepovitz C; Farruggella T; Levine R; Lane B; Kaloyanides GJ
J Pharmacol Exp Ther; 1985 Dec; 235(3):810-9. PubMed ID: 3001278
[TBL] [Abstract][Full Text] [Related]
8. Newborn response to cationic amphiphilic drugs.
Kacew S; Reasor MJ
Fed Proc; 1985 Apr; 44(7):2323-7. PubMed ID: 2579857
[TBL] [Abstract][Full Text] [Related]
9. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
Coulombe PA; Bendayan M
J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
[TBL] [Abstract][Full Text] [Related]
10. Increased lysosomal enzyme activities in tissues of rats suffering from chlorphentermine induced lipidosis.
Lüllmann H; Mösinger EU
Biochem Pharmacol; 1979 Apr; 28(7):1015-6. PubMed ID: 109091
[No Abstract] [Full Text] [Related]
11. Chlorphentermine-induced alterations in pulmonary phospholipid content in rats.
Kacew S; Reasor MJ
Biochem Pharmacol; 1983 Sep; 32(18):2683-8. PubMed ID: 6626239
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
McCloud CM; Beard TL; Kacew S; Reasor MJ
Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
14. Alterations in rat alveolar surfactant phospholipids and proteins induced by administration of chlorphentermine.
Miles PR; Bowman L; Tucker J; Reasor MJ; Wright JR
Biochim Biophys Acta; 1986 Jun; 877(1):167-78. PubMed ID: 3755061
[TBL] [Abstract][Full Text] [Related]
15. Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking.
Sundin DP; Sandoval R; Molitoris BA
J Am Soc Nephrol; 2001 Jan; 12(1):114-123. PubMed ID: 11134257
[TBL] [Abstract][Full Text] [Related]
16. Role of age in amphiphilic drug-induced pulmonary morphological and metabolic responses.
Kacew S
Fed Proc; 1984 Aug; 43(11):2592-6. PubMed ID: 6146538
[TBL] [Abstract][Full Text] [Related]
17. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
Heyneman CA; Reasor MJ
J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
20. Alterations in renal cortical phospholipid content induced by gentamicin: time course, specificity, and subcellular localization.
Knauss TC; Weinberg JM; Humes HD
Am J Physiol; 1983 May; 244(5):F535-46. PubMed ID: 6846542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
